OXYINK Trademark

Trademark Overview


On Friday, August 12, 2016, a trademark application was filed for OXYINK with the United States Patent and Trademark Office. The USPTO has given the OXYINK trademark a serial number of 87137208. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Tuesday, September 26, 2017. This trademark is owned by OXYBAND TECHNOLOGIES, INC.. The OXYINK trademark is filed in the Pharmaceutical Products category with the following description:

Antibiotic creams; Antibiotic ointments; Antibiotic preparations; Antifungal creams for medical use; Antifungal preparations; Antimicrobial preparations for treating combat battle field wounds; Antimicrobials for dermatologic use; Oxygen for medical purposes; Oxygen for medical use; Pain relief medication; Wound dressings; Adhesive for bandages for skin wounds; Adhesive for bandages for skin wounds; Bandages for skin wounds; Bandages for skin wounds; Biological tissue cultures for medical purposes; Biological tissue grafts; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Dressings for combat battle field wounds; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Hemostatic gel matrix preparations for treating wounds; Human allograft tissue; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Medical adh...
oxyink

General Information


Serial Number87137208
Word MarkOXYINK
Filing DateFriday, August 12, 2016
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateTuesday, September 26, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements


Goods and ServicesAntibiotic creams; Antibiotic ointments; Antibiotic preparations; Antifungal creams for medical use; Antifungal preparations; Antimicrobial preparations for treating combat battle field wounds; Antimicrobials for dermatologic use; Oxygen for medical purposes; Oxygen for medical use; Pain relief medication; Wound dressings; Adhesive for bandages for skin wounds; Adhesive for bandages for skin wounds; Bandages for skin wounds; Bandages for skin wounds; Biological tissue cultures for medical purposes; Biological tissue grafts; Biostatic antimicrobial preparations for treating bacteria, mold, mildew, algae and yeast and for inhibiting growth of those organisms; Dressings for combat battle field wounds; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Hemostatic gel matrix preparations for treating wounds; Human allograft tissue; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Medical adhesives for binding wounds; Medicaments for recovery of combat battle field wounds; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mixed antibiotic preparations; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical skin lotions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for wounds; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for treating skin disorders; Processed human donor skin for the replacement of soft tissue; Processed human donor skin for the replacement of soft tissue; Surgical implants comprised of living tissues; Surgical implants comprising living tissue; Surgical mesh comprised primarily of living tissue; Therapeutic agents for delivery of oxygen to human tissue; Therapeutic agents for delivery of oxygen to human tissue; Vascular grafts; silver iodide for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, September 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOXYBAND TECHNOLOGIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt Louis, MO 63132

Party NameOXYBAND TECHNOLOGIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt Louis, MO 63132

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2017ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Tuesday, September 26, 2017ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, September 26, 2017OPPOSITION TERMINATED NO. 999999
Tuesday, September 26, 2017OPPOSITION SUSTAINED NO. 999999
Friday, June 9, 2017OPPOSITION INSTITUTED NO. 999999
Friday, June 9, 2017OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, April 26, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 26, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, April 26, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2016NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 21, 2016ASSIGNED TO EXAMINER
Thursday, August 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 16, 2016NEW APPLICATION ENTERED IN TRAM